“Bladder Cancer Diagnosis and Monitoring Based on Urine Survivin (BIRC5) Bioluminescence-Based Immunoassay” (2026) Voprosy onkologii, 72(2), p. OF-2510. doi:10.37469/0507-3758-2026-72-2-OF-2510.